REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 51 filers reported holding REGULUS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $26,000 | -73.7% | 132,607 | -11.8% | 0.00% | – |
Q2 2018 | $99,000 | -6.6% | 150,299 | +2.5% | 0.00% | – |
Q1 2018 | $106,000 | -7.0% | 146,607 | +33.8% | 0.00% | – |
Q4 2017 | $114,000 | -37.7% | 109,607 | -25.2% | 0.00% | – |
Q3 2017 | $183,000 | +0.5% | 146,541 | -20.4% | 0.00% | – |
Q2 2017 | $182,000 | -32.6% | 184,040 | +12.1% | 0.00% | – |
Q1 2017 | $270,000 | -27.8% | 164,106 | -1.2% | 0.00% | – |
Q4 2016 | $374,000 | -43.6% | 166,051 | -17.4% | 0.00% | – |
Q3 2016 | $663,000 | +3.0% | 201,033 | -9.7% | 0.00% | – |
Q2 2016 | $644,000 | -58.1% | 222,690 | +0.3% | 0.00% | -100.0% |
Q1 2016 | $1,538,000 | -15.9% | 222,004 | +5.8% | 0.00% | 0.0% |
Q4 2015 | $1,829,000 | +43.3% | 209,754 | +7.4% | 0.00% | 0.0% |
Q3 2015 | $1,276,000 | -43.4% | 195,311 | -5.1% | 0.00% | -50.0% |
Q2 2015 | $2,255,000 | -31.3% | 205,751 | +6.1% | 0.00% | 0.0% |
Q1 2015 | $3,284,000 | +41.9% | 193,851 | +34.4% | 0.00% | +100.0% |
Q4 2014 | $2,314,000 | +241.3% | 144,274 | +45.4% | 0.00% | – |
Q3 2014 | $678,000 | +0.4% | 99,223 | +18.2% | 0.00% | – |
Q2 2014 | $675,000 | +58.1% | 83,923 | +77.4% | 0.00% | – |
Q1 2014 | $427,000 | +379.8% | 47,300 | +294.2% | 0.00% | – |
Q4 2013 | $89,000 | -21.2% | 12,000 | -0.1% | 0.00% | – |
Q3 2013 | $113,000 | +91.5% | 12,017 | +100.3% | 0.00% | – |
Q2 2013 | $59,000 | – | 6,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|